Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation.

Background/Aims: A meta-analysis was undertaken to assess the effect of triptorelin 11.25 mg 3-month prolongedrelease formulation in central precocious puberty […]

See Post

Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial

Background Diphereline is a Gonadotropin-Releasing Hormone agonist commonly used in patients with breast cancer. This study aimed to compare the […]

See Post

Evaluating triptorelin as a treatment option for breast cancer

Introduction: Triptorelin is a luteinizing hormone-releasing hormone analog (LH-RHa) inducing ovarian function suppression (OFS). It is approved by FDA and […]

See Post
1 2 3

Registered Articles

Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation.

Background/Aims: A meta-analysis was undertaken to assess the effect of triptorelin 11.25 mg 3-month prolongedrelease formulation in central precocious puberty […]

 See

Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide

Purpose: To investigate the changes in testosterone levels and rates of chemical castration following androgen-deprivation thera- py (ADT) with goserelin, […]

 See

Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized Clinical Trial

Background: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC). Triptorelin is a synthetic GnRH and many […]

 See

Homa Pharmed Blogs

Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide

Purpose: To investigate the changes in testosterone levels and rates of chemical castration following androgen-deprivation thera- py (ADT) with goserelin, […]

 See

Comparison of the Efficacy of Two Brands of Triptorelin (Microrelin and Diphereline) in Reducing Prostate-Specific Antigen and Serum Testosterone in Prostate Cancer: A Double-Blinded Randomized Clinical Trial

Background: Gonadotropin-releasing hormone (GnRH) agonists initiate androgen deprivation in treating prostate cancer (PC). Triptorelin is a synthetic GnRH and many […]

 See

The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysisThe effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis

Background: This study aimed to explore the effects of triptorelin and leuprolide on serum hormone levels and the clinical efficacy […]

 See

Meta-Analysis of Paediatric Patients with Central Precocious Puberty Treated with Intramuscular Triptorelin 11.25 mg 3-Month Prolonged-Release Formulation

Background/Aims: A meta-analysis was undertaken to as- sess the effect of triptorelin 11.25 mg 3-month prolonged- release formulation in central […]

 See

Patient Support

The Patient Support Unit at Homa Pharmed Pharmaceutical is dedicated to providing personalized assistance and guidance to patients, ensuring they receive the necessary support throughout their treatment journey. We are committed to improving patient outcomes by offering timely information and resources.

see more

Home

Contact

No.26, Nader Alley, Parvin St, West Fatemi St. Tehran, Iran

+98 21 62769000

info@homapharmed.com

Subscribe Us
Copyright @Dotline 2023